Diagnostic Imaging: Clinical Trials

13 trials of Diagnostic Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 active not recruiting, 3 recruiting, 2 completed, 2 terminated. 13 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 113Active not recruiting 5, Recruiting 3, Completed 2, Terminated 2, Not yet recruiting 1
Phase 24Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1

Follow Diagnostic Imaging: new trials by email Literature Review of Diagnostic Imaging trials Research Report on Diagnostic Imaging

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma
Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)312027-06-012026-10-22
Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Malignant Solid Neoplasm, Recurrent Childhood Neuroblastoma
Phase 1 / Phase 2Not yet recruitingChildren's Oncology Group772027-04-092026-09-15
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Biospecimen Collection, Cholestyramine, Computed Tomography - Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8
Phase 1Active not recruitingCity of Hope Medical Center192024-06-102026-11-10
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
Abemaciclib, BET Bromodomain Inhibitor ZEN-3694, Biopsy Procedure - Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8
Phase 1RecruitingNational Cancer Institute (NCI)452023-08-102026-11-12
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm
Phase 1RecruitingNational Cancer Institute (NCI)432023-07-062026-08-03
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
Pre-operative abemaciclib, Device for Cerebral Fluid Dialysate Collection, Ashion Analytics GEM ExTra - Glioma
Phase 1Active not recruitingNational Cancer Institute (NCI)52023-04-072026-10-06
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR - Kita-kyushu Lung Cancer Antigen 1, Human
Phase 1TerminatedNational Cancer Institute (NCI)362022-03-082025-12-02
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines
Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Colorectal Carcinoma, Advanced Digestive System Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)102021-08-132026-11-13
Testing the Addition of an Anti-cancer Drug, Elimusertib (BAY 1895344) ATR Inhibitor, to the Chemotherapy Treatment (Gemcitabine) for Advanced Pancreatic and Ovarian Cancer, and Advanced Solid Tumors
Biopsy Procedure, Biospecimen Collection, Diagnostic Imaging Testing - Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm
Phase 1Active not recruitingNational Cancer Institute (NCI)142021-06-012026-11-13
Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
Abemaciclib, Biopsy Procedure, Biospecimen Collection - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma
Phase 1Active not recruitingNational Cancer Institute (NCI)242020-06-172026-11-13
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 Patients
Cyclophosphamide, Fludarabine, Aldesleukin - Gastrointestinal Cancer, Pancreatic Cancer
Phase 1 / Phase 2TerminatedNational Cancer Institute (NCI)52019-05-162026-05-19
Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer
Glutaminase Inhibitor CB-839, Panitumumab, Irinotecan Hydrochloride (phase I only) - Colorectal Cancer, Metastatic Colorectal Cancer
Phase 1 / Phase 2CompletedVanderbilt-Ingram Cancer Center292017-08-232024-08-30
Tissue Oxygenation Measurements With Modulated Light (S-FLARE)
Imaging with S-FLARE imaging system - Breast Cancer
Phase 1CompletedBeth Israel Deaconess Medical Center42010-01-012013-02-18

Conditions studied

Pancreatic Neoplasms (4)  ·  Breast Neoplasms (3)  ·  Neoplasm Metastasis (3)  ·  Colorectal Neoplasms (2)  ·  Stomach Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Carcinoma (1)  ·  Colonic Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Glioma (1)  ·  Ovarian Neoplasms (1)  ·  Rectal Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

National Cancer Institute (NCI) (9)  ·  Beth Israel Deaconess Medical Center (1)  ·  Children's Oncology Group (1)  ·  City of Hope Medical Center (1)  ·  Vanderbilt-Ingram Cancer Center (1)

Countries

United States (12)  ·  Canada (1)

Top investigators

Amit J Sabnis (1)  ·  Cynthia X Ma (1)  ·  Geoffrey I Shapiro (1)  ·  James C Yang, M.D. (1)  ·  James M Cleary (1)  ·  Jia Luo (1)  ·  John V. Frangioni, MD, PhD (1)  ·  Jordan Berlin, MD (1)  ·  Liza C Villaruz (1)  ·  Sadhana Jackson, M.D. (1)  ·  Scott M Norberg, D.O. (1)  ·  Vincent Chung (1)

Results publications

PMID 37682953, PMID 39841295

NIH funding

UM1CA186709 (3), UM1CA186689 (2), P30CA033572 (1), UM1CA186690 (1), UM1CA186704 (1), UM1CA228823 (1)